This December, one big trial on psilocybin for depression came out. Unlike other trials, the dose was relatively modest, given once, and the results were

Throughout November, we gained some fascinating new insights into the potential of psychedelic medicine as researchers from some of the world’s leading institutions published their

October was a relatively quiet month for psychedelic research. Nonetheless, we still gained some valuable new insights into the world of psychedelics. Natural language processing

September was an exciting month for many psychedelic researchers. Over the past month, we gained some positive insights into the effectiveness of ketamine infusions and esketamine using real-world data

Psychedelics put to the test One of the most significant developments this summer was the results of the first double-blind, active placebo-controlled study to test psilocybin for alcohol

Summer is officially here, and psychedelic researchers are continuing their efforts to turn these medicines into viable therapy options. Despite relatively few clinical trials published